Steve Mertens Neuroone Medical Technologies Corp (NMTC) insider trading activity

Steve Mertens is Chief Technology Officer of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 162,235 shares of NMTC, which is worth approximately $120,053. The most recent transaction as insider was on Jun 30, 2023, when has been sold 252 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $302. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

0.56% 3M change

7.29% 12M change

Total Value Held $120,053

Steve Mertens Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2023	SELL Payment of exercise price or tax liability	$302 $1.2 p/Share	252 Reduced 0.3%	84,688 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$304 $1.21 p/Share	252 Reduced 0.3%	84,940 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$388 $1.54 p/Share	252 Reduced 0.29%	85,192 Common Stock
Apr 21 2023	BUY Grant, award, or other acquisition	-	50,000 Added 36.92%	85,444 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$405 $1.61 p/Share	252 Reduced 0.71%	35,444 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$8,899 $1.47 p/Share	6,054 Reduced 14.5%	35,696 Common Stock
Feb 03 2022	BUY Grant, award, or other acquisition	-	41,750 Added 50.0%	41,750 Common Stock

Steve Mertens

Chief Technology Officer

Eden Prairie, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Value

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC

Account